Tizona Appoints Christine O’Brien as Chief Executive Officer
15 sept. 2020 09h00 HE
|
Tizona Therapeutics Inc
-- Transaction with Gilead Sciences Closed -- -- Tizona Advances TTX-080, a Novel Anti-HLA-G Antibody, with First Patients Treated in Phase I Study – SOUTH SAN FRANCISCO, Calif., Sept. 15, 2020 ...
Thesecondopinion to Host Dr. Robert M. Sapolsky, Acclaimed Best-Selling Author, Stress Expert, Biologist and Neuroscientist
19 févr. 2020 09h00 HE
|
Thesecondopinion
SAN FRANCISCO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Thesecondopinion, a nonprofit offering free multidisciplinary, comprehensive second opinions to adults diagnosed with new or recurrent cancers,...
Tizona to Present at The Cowen and Company 40th Annual Healthcare Conference
19 févr. 2020 09h00 HE
|
Tizona Therapeutics Inc
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Tizona Therapeutics, Inc., a clinical stage, privately held company developing first-in-class cancer immunotherapies, announced today...
Tizona Elects Daniel K. Spiegelman to Its Board of Directors
15 mai 2019 16h00 HE
|
Tizona Therapeutics Inc
SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Tizona Therapeutics, Inc., a privately held immunotherapy company, today announced the appointment of Daniel K. Spiegelman to its Board...
Lodonal™ Expected to Receive International Exposure at the World Health Assembly, one of the World’s Leading Health Forums
18 mai 2016 14h05 HE
|
Immune Therapeutics, Inc.
ORLANDO, Fla., May 18, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and...
2016 Bio-IT World Best Practices Awards Winners Announced in Boston at Bio-IT World Expo
06 avr. 2016 10h30 HE
|
Bio-IT World
BOSTON, MA--(Marketwired - April 06, 2016) -
Bio-IT World announced the winners of the 2016 Best Practices Awards this morning at Cambridge Healthtech Institute's Fifteenth Annual Bio-IT...